Lapsed GLP-1 Households Cut Fast-Food Spending More
US households that stopped GLP-1 weight-loss drugs reduced limited-service restaurant spending more than households still on them.
Updated on Nov. 2, 2026 in Weight Loss

Live Poll
Have your household's fast-food and grocery purchases gotten smaller over the past year?
Households whose members stopped using GLP-1 weight-loss drugs cut restaurant spending more sharply than households still using them, according to Numerator purchase data for the 12 months ended Sept. 30. Lapsed-user households, an estimated 12.3 million in the US, spent more than $166 billion a year on groceries and fast food, and the findings were published Nov. 2, 2026.
Why it matters
The data suggest that changes in medication use may ripple into everyday food purchasing, a pattern that matters for people managing weight, appetite, and eating habits. Because the analysis compares spending between two groups rather than tracking individual diets, it describes buying patterns rather than health outcomes.
This is a retrospective analysis of consumer purchase data covering households with and without recent GLP-1 use over the 12 months ended Sept. 30. It reports household-level spending changes, not individual dietary or health measurements.
The players
Numerator
A Chicago-based consumer research firm that tracks household purchase behavior through panel data.
The details
GLP-1 medications act on appetite-regulating hormone pathways, which can reduce hunger and food cravings for many users. Numerator's analysis suggests that when people stop taking these drugs, their household spending patterns can shift, with a notable decline at some fast-food chains. Subway, Arby's, Domino's, and McDonald's all saw lower spending from lapsed-user households, while Costco and Walmart saw modest increases.
Timeline
Purchase data analyzed covered the 12 months ended Sept. 30, 2026.
Numerator published its findings on Nov. 2, 2026.
Health Landscape
GLP-1 drugs have become widely used for weight management, and their effects on eating behavior are an active area of study. Purchase-panel research like this offers a population-level view of how medication use may connect to everyday food spending.
If you have stopped a GLP-1 medication, changes in appetite and eating habits are worth discussing with your doctor as you plan your next steps. Anyone tracking food spending or meal patterns may find these population trends a useful reference point.
The takeaway
Household spending patterns can shift when GLP-1 medication use changes, and the decline was steepest at certain fast-food chains. If you are considering a change in your medication or eating plan, talk with your physician first.
Further reading
For more on how medications and eating habits interact, explore our Weight Loss coverage.
Source note: This article includes information reported by FoodBusinessNews.
Live Poll
Have your household's fast-food and grocery purchases gotten smaller over the past year?





